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· CHAPTER I 
LITERATURE REVIEW 
Discovery and Identification of the Pyridine Nucleotides 
Early in the twentieth century, Harden and Young (1, 2) noticed an 
increase .in the fermentation of sugar to alcohol and carbon dioxide 
after the addition of boiled yeast juice to fermenting yeast extracts., 
Upon dialysing the boiled juice, this effect was lost and it was eon~ 
eluded that whatever was effecting the fermentation increase passed 
through the dialysis bag into the dialysate. These investigators pro-
ic:eeded to study the factor or factors involved by ultracentrifugation, 
separating the yeast juice into a residue and a.filtrate. Each com-
ponent was unable to ferment glucose alone wh~reas when combined, a 
fermentation rate comparable with that of the original juice was ob-
tainedo 
These exper~ments led to the conclusion that not only was a 
,. proteinaceous substance required for fermentation bu-t also an addi-
tional factor which von Euler ar1d Myrback (3) called "cozymase .. n This 
name was given because Buchner (4) held the theory that fermentation of 
yeast was caused 'by a single proteinac~ous substap.ce called "zymaseo ,v 
As noted in the preceding paragraph, ttcozymase" is dialysable and 
thermostableo 
When Meyerhof (5 1 6) observed that "cozymase" of alcoholic fermen-
tation was also present in milk and mammalian tissue 9 a greater 
1 
interes.t w~s stimulated in the physiological role. of what was to be 
identified later as pyridine nucleotides. F'tlrt~ermore, he observed 
that yeast "cozymase" activated lactic acid formation in muscle while 
at the same time "cozymase" of muscle.activated "zymase" of yeasto 
After many efforts to isolate and purify "cozymase," von Euler. 
and Myrback (7) succeeded in obtaining a purified preparation. The 
purified preparation was found to contain adenine, phosphate, and an 
uni;dentified carbohydrate upon acid hydrolysis (8). 
2 
During this time, Warburg and. Cllristian (9), studying the oxidation 
of gluoose'"".6-phosphate in red 'blood cells, found that .they.were able to 
separate the components of tlris system :into "ferment" which was a pro-
tein factor and a "ooferment" a non-proteinaceous substance. "Co-
f'erment" yielded two bases upon acid hydrolysis, one of which was 
adenine (10). Carbohydrate and phosphate were also found in this 
bydrolysate •. · The second base was found to take up thre~ moles of 
hydrogen when a picroJ.inate salt of the base was stirred in with finely 
divided palladium (11). Late.r thE3y showed this base to be nicotin-
amide (12). Von Euler ,!1 &• (13) then found.that "oozymase" a.lso 
contained niootinamide. 
Although not the same, "cozymase" a.nd."eoferment" were very 
simil.ar. "Cofe~ent" could not substitute for "cozymase" in the a.po-
zymase system as shown by Warburg and Christian (10) •. Furtherm<>re, 
"ooferment" contained a higher phosphate content than "cozyma.se" and 
vo:n Euler and Adler (14) no.ticed that partially pure "cozymase" was 
active in the alcohol dehyd.rogenase system but not in the glucose-6-
phosphate dehydrogenase system~ In addition von Euler and Adler (15) 
and Warburg and Christian (16) working independently, showed that 
wcczymase9' and "coferment" were both present in horse erythrocytes and 
that 911coferment'' could be selectively adsorbed on aluminum oxideo 
Enough evidence had accumulated by this time to show that both 
tvcozymase" and "coferment" conte.i.ned to one mole of adenine (8), one 
mole of nicotinamide (12 7 13), and two moles of carbohydrate at least 
orte of which was ribose (17, 18).. In addition, "cozymase" contained 
two moles of phosphate while "cof'erment" contained three. 
As a result of the investigations of von Euler, Schlenk, and 
Warburg, the structure of "cozymase," later known as diphosphopyridine 
nucleotide (DPN) and now called nicotinamide adenine dinucleotide 
(NAD+) 1, was established (Fi~re 1). Hydrolysis in dilute base at low 
temperatuxe yielded nicotinamide, adenylic acid, and adenosine diphos-
phate (19)., while at high temperatures adenosine diphospha.te was the 
most abundant producto Upon acid hydrolysis, D-ribose-5-phosphate 
(17 9 20) was isolated. When incubated with.a "phosphatase" from 
alrrmnd p:ress cake, niootinamide ribose was obtained (21-23)., The 
ribose was identified as D-ribose by formation of a derivative with p-
bromophenylhydrazone (24). 
99CofermentVt or triphosphopyridine nucleotide (TPN) now cal.led 
:nicotina.mide adenine dinucleotide phospha·te (NADP+) had already been 
shown to contain an additional phosphate over "cozymase" (25)o It 
1All abbreviations used are those specified in the Journal of 
Biological Chemistry. For those no·t appearing in this journal, the 
following are used; NaMNv nicotinic acid mononucleotide; NAR1 nico-
tin.ic acid ribose;· des-NAD+, desamido NAD+i ARPPR, adenosine diphos-
phate r:i.bose; APNAD+v 3-acetylpyridine .NAD ; PRPP, 5-phosphoribosyl-1-
pyrophosphate; NA, nicotinic acid; QA.7 q-ainolinic acid; ACTH, adreno-
corticotropic hormone; POPOP 1 1,4-bis-[2-(5-phen.yloxazolyl)]-benzene; 
PPO, 2v5'.""d:iphenyloxazole; DEAE cellulose, diethylaminoethyl cellulose; 
ADP-methylene-P, adenyl diphosphonate {;s',r-methylene)-phosphate. 
3 
Figure 1o 
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could also be shown that ~cozyrnase°' was converted to NADP+ in the 
presence of yeast extract and ATP (26) and although in a smaller yield, 
in the presence of phosphorus o:x:ychloride (27), while NADP+ could be 
converted to NAD+ with a phosphatase preparation (28). 
At first it was thought that the three phosphate groups were 
linked together in pyrophosphate linkages, but it was later found that 
one of the phosphates was not easily hydrolysed relative to the other 
two. Also ADP could be fonned from NAD+ whereas it could not be from 
NADP+ (29)o Therefore Schlenk suggested that the third phosphate might 
be attached to the second or third carbon atom of the ribose moiety of 
adenosine. In 1949, Cohn and Carter (30) showed that yeast adenylio 
aoid could be separated into two factions, adenylic acid "a" and 
adenylic acid "b." Although it could not be determined for sure which 
compound was adenosine-3v-phosphate and which was adenosine-2V-phos-
phate, enzymatic degradation of NADP+ produced an adenylic acid "a," 
and was different from adenosine-5'-phosphate, adenosine-3'-phosphate, 
or adenylic acid "b" (31, 32). The third phosphate was tentatively 
presumed to be attached to the second carbon atom of ribose and the 
validity of this assumption was proven unequivocally by Khym ~ alo 
(33)o Dowex-50 hydrolyzed adenlyic acid "a" to the free base and the 
21-phosphate ribose ester which was immediately released from the resin, 
thus isomerization or exchange of the phosphate group to another carbon 
was improbableo This ribose phosphate consumed one mole of period.ate 
when converted to methyl ribose pyranoside and had marked optical 
activity when converted to a ribitolo These findings would indicate 
that t he phosphate was on carbor. 2o The ribose phosphate from 
, adenylic acid "b" had none of these properties, thus the phosphate was 
'7 
i 
on carbon-3o The structural formula of NADP+ is also shown in Figure 1., 
In addition to finding that nicotinamide was a component in the 
pyridine nucleotides, it was also observed that this moiety was actu-
ally involved in hydrogen transfer (18, 25, 34). Warburg~&" (25) 
demonstrated a stoichiometric relationship between the amount of glu-
cose-6-phosphate and NADP+ consumed and the amount of 6-phosphoglu-
conic acid and NADPH produced in the presence of glucose-6-phosphate 
dehydrogenase which was free of the old yellow enzyme. Furthermore, in 
t:b.e presence of palladium, oxidized NADP+ took up six moles of hydrogen 
+ while reduced NADP took up only four. It was thus concluded that 
NADP+ took up hydrogen during the oxidation of glucose-6-phosphate. 
Warburg~~. (25) observed that NADP+ exhibited an absorption 
band with a maximum at 340 mp. when reduced to NADPH, even when re-
duced chemically with Na2s2o4• Similar results could be obtained with 
NAD+ (35 1 36). Other pyridinium compounds such as N'-methyl nicotin-
amide iodide (36), trigonelline (25), and tetraacetyl gluoosido-
nicotinamide bromide (37) also could be observed to show changes in 
their absorption spectrum with a maximum at about 340 mp.. The latter 
two compounds released. one mole of acid per mole of compound when 
reduced with di thioni te (38)., Thus, enzymatic and chemical reductior1 
was concluded to proceed as shown in Figure 1. 
Previous observations (39-41) gave indication that reduction of 
N°-methyl nicotinamide by Na2s2o4 occurred at the ortho position. 
Colowick and coworkers (42i 43) later reduced NAD+ chemically in n2o 
and then enzymatically oxidized it by substrateo They found that when 
this NAD+ was converted to 1-methyl-2-pyridone-3-carboxamide and ·t-
methyl-6-pyxidone-3-carboxamide, the two derivatives contained equal 
amounts of deuteriumo They e:xplained these observations by asSQ.ming 
that.reduction ocCUTred at the four or para position of the nicotin-
amide.. Loewus !! .!lo (44) confirmed Colowick' s work and showed un-
equivocally· that hydrogen transfer occurred at the para.position by 
preparing 2, 4, and 6 deute:rium labeled NAD+. Only deuterium labeled . 
in the 4 position transferred deuterium to pyruvate in the presence 
of lacti.c acid dehydrogenaseo In addition to this evidence, two model 
compounds, 1-benzyl-dihydro-nicotinamide (45) and N'-metbyl-nicotin-
amide (46) were shown to transfer hydrogen chemically from the para 
positiono 
In 1958, two PJ'l'idine nucleotides containing nicotinic acid were 
observed by Preiss and Handler (47, 48), to occur in human erythro-
cytes. These were identified as nicotinic acid mononucleotide 
and desamido N.A.D+ by paper chromatography and chromatography over 
Dowex-1-formate. Des-NAD+ was identified by comparing its chemical 
properties with the compound which Kapla.n 9 s group had chemically 
prepared earl_ier (49). Na.MN was identified by observing its molar 
8 
ratio of nicotinic acid, ribose, and phosphate in a ratio of 1:1.15:100, 
respectivelyo Yeast (50), mold (51), bacteria (52, 53), and plants 
(54) also contain Na.MN. 
Properties of the PJ'l'idine Nucleotides 
Several properties which are peculiar to the PJ'l'idine nucleotides 
' . ) 
were first observed during their. isolation and characterization (10, 
25, 55, 56). The oxidized coenzymes are labile in base but relatively 
stable in acid, while just the opposite is true for the reduced forms .. 
Degradation at neutrality is primarily due to hydrolysis of the gly-
cosyl linkage between the pyridine and ribose moieties. This is shown 
by the _fact that dilute alkali (0.1 to 1 N NaOH) at room temperature 
will hydrolyze NAD+ to yield free nicotinamide much more readily than 
adenylic acid. In contrast, in stro~g base (5 N KOH) NAD+ is degraded 
to yield a highly fluorescent substance or group of substances with an 
absorption maximum at 360 mp. (57), while only a small amount of free 
nicotinamide i~ given off _under these circumstances. 
9 
The reduced forms of pyridine nucleotides are even more sensitive 
to a.cid degradation than are the oxidized to alkali. In 0.1 ~ acids at 
room temperature, both NA.DH and NADPH along with the reduced forms of 
N' substituted nicotinamide compounds instantly degrade-to lose their 
fluorescence and simultaneously a _ hypochromic shift occurs in the 
340 mp. band (10, 34, 52, 58, 59). The probable site of action of the 
hydronium ion is the nicotinamide ring where the primary produ_ct 
formed is slowly converted to another compound with a maximum absorp-
tion at about 290 mp. (60). This second reaction can be inhibited with 
bisulfite. 
It was noted by Meyerhof and his coworkers .(61) that bisulfite 
and cyanide form addition compounds with pyridine nucleotides which 
have absorption maximums at 320 and 325 RJ1, respectively. It has since 
been found that this is a general reaction for all N' substi tu_ted 
pyridine compounds (62). The pyridine nucleotide call: be easily re-
generated from the bisulfite addition compounds with the addition of 
dilute alkali or merely by dilution with water. In spite of the fact 
that the NAD+ addition compound closely resembles NADH in its absorp-
tion spectrum, it cannot replace NADH in enzymatic reacti.ons. 
Cyanide apparently attacks the para position of the pyridine ring 
10 
since it can be shown that a deuterium atom is acquired when the com-
plex is formed in the presence ot D20 and this atom oan be transferred 
in enzymatic reactions where NAD+ is regenerated from the complex (63). 
Furthennore, decomposition of the complex in the presence ot D20 by 
reacting with dithionite to produce NADH, introduces a deuterium atom 
into NADH which also can be transferred in enzymatic reactions that 
reoxidize NADH to NAD+ (64). Thus the pyridinium ring takes on an 
aldehydic nature and this can be further illustrated by reacting NAD+ 
with carbonyl compounds (65) and hydroxylamine (66). Pyridine nucleo-
tides containing nicotinic acid instead of nicotinamide also behave in 
this manner, each giving an absorption maximum of 315 mµ and 315 to 
360 mµ, respectively. 
Although much work has been done on the mechanism by which co-
enzymes function in biological oxidation reactions the detailed 
mechanism has yet td be explained. Vennesland and Westheimer (67) and 
Westheimer (68) and others have shown that a hydrogen i s directly 
transferred (69) and that t.he;se ~ransfers are stereospecific (70-72) 
by the use of deuterium. Even more interesting is the fact that some 
enzymes only transfer hydrogen from one side of the ring while other 
enzymes transfer hydrogen only from the other (73-76). 
Using NADH and N'-benzyldihydronicotinamide to reduce thiobenzo-
phenone as a model system for studying hydrogen ion transfer (77), a 
mechanism has been postulated from studies of reaction kinetics and 
solvent and isotope effects. This postulate involves a direct transfer 
ot a hydride ion from the dihydro compound to the thioketone through an 
activated state. Another hypothesis includes a free radical but no 
evidence in so tar aa inhibiting the reaction with free radical traps 
(45) have been shown 9 while in contrast, much data have been shown in 
the case of the hydride ion theory. 
A destruction of N.ADH also occurs with triose phosphate dehydro-
genase (78), giving a reaction product "N.ADH-X" with an absorption 
11 
peak at 290 mp. and an al·tered optical rotation. "NADH-X" differs from 
the acid degradation product in its altered optical rotation. It has 
enzymatic activity in that it can be slowly converted to NADH by a 
yeast kinase (79). Data such as isotope and spectrophotometric studies 
give evidence that "NADH-X" is a hydrated product having one water 
molecule inserted into the pyridine ring (80, 81). The metabolic 
' significance of these results cannot be assessed at this time. 
Determination of the Pyridine Nucleotides 
Following is a list of the principles by which pyridine nucleo-
tides are assayed in biological systems: 
1) Measurements of the rate of CO2 production 7' dye decolor~ 
tion, or o:x;ygen uptake which is proportional with the amount of pyri-
dine nucleotide presento 








Chromatography and electrophoresis. 
Radioactive isotopese 
Employment of a recycling technique in which the nucleotide 
undergoes a cyclic' oxidation and reduction as a component member of a 
series of coupled reactions, and the extent of the reaction is meas-
ured by the accumulation of an end product. 
12 
The most common method used at first for determining pyridine 
nucleotides was that used by Myrback (8), who found that dried washed 
brewers yeast would glycolyze at a rate dependent upon "cozymase" 
present when catalytic amounts of hexose diphosphate and magnesium ions 
were added. The reaction was followed by evolution of CO2 and activity 
was expressed as volume of CO2 per unit time per weight of "cozymase" 
tested, since the molecular weight was not known at that time. Since 
then, the development of the Warburg apparatus and NAD+ standards 
(82-84) and later further modifications have proven this technique to 
be quite sensitive (84). This reaction may also be followed by 
assessing dye decoloration using such dyes as methylene blue (85), 
2,6-dichlorophenol indophenol, or cytochrome c (86, 87). More recently, 
this method has been used with specific dehydrogenases [alcohol de-
hydrogenase (alcohol:NAD oxidoreductase EC 1.1.1.1) for NAD+ and 
glucose-6-phosphate dehydrogenase (D-glucose-6-phosphate:NADP oxido-
reductase EC 1.1.1.49) for NADP+] and a non specific dehydrogenase 
(diaphorase) and followed by measuring the rate of decoloration or 
coloration of 2,6-dichlorophenol-indophenol (88). 
Microbiological assay procedures were used extensively in the 
early 194o•s. These involved determining the growth rate of Hemophilus 
influenza_or Ji• parainfluenza on limiting quantities of pyridine nucleo-
tides (82-92). The main objection to this method is that they are very 
slow and non specific as to the pyridine nucleotides (93, 94). 
Spectrophotometry is currently one of the most common methods for 
determining pyridine nucleotide concentration. This method, which 
measures absorption at 340 lll)l upon reduction of the coenzymes (25), 
will show an optical density increment of 0.06 absorbancy units with 
13 
as little change in concentration as 0.01 mM. NAD+ may be assayed with 
either yeast or beef liver alcohol dehydrogenase (95, 96), reduction 
being complete at pH 10 in the presence of excess substratee NADH is 
determined with these enzymes at neutral pH (97). NADP+ can be assayed 
using NADP+ specific isocitrate dehydrogenase (L -isocitrate:NADP oxido-. . s . 
reductase EC 1o1.1042) (98-100), yea.st glucose-6-phosphate dehydrogen'."' 
ase, or pigeon liver malic enzyme (101), while NADPH is assayed with glu-
tathione or cytochrome c reductase (NADP:glutathione reductase EC 1.6.4. 
2 and NADP:cytochrome c reductase EC 1.60203 respectively) (87, 102). 
Des-NAD+ and NaMN can be assayed by co.nversion to NAD+ with their re-
spective enzymes and .then assaying for NAD+ (48, 103). Chemically in-
duced spectral changes can be used in place of biologically introduced 
changes using cyanide formation to detect nicotinamide ribose compounds 
(62). These compounds exhibit an absorption maximum at 325 mp. while 
the nicotinic acid analogs have a band at 315 mµ (47, 49). 
Another method used for determination of pyridine nucleotides is 
the method of fluoremetry (54), which is sensitive enough to determine 
a concentration as low as 10-S M (104). Thus since volumes as small 
-13 as 0.01 ml may be used, as little .as 10 moles of oxidized or re-
duced pyridine nucleotide may be detected. Two major objections to 
this method a.re that various :foreign substa.l'l.ces are known ·to :i.nfluence 
fluorescence (104, ·105) and the difficulty e11oo·untered in rate studies. 
However this latter difficulty has been eased somewhat by more sophis-
ticated inst:rumentation (106). Fluorescence of the oxidized form is 
' .. 
developed by strong base (6 N Na.OH). The undesired form of the nucleo-
tide is destroyed by changing the pH and then determination of the 
remaining form is performed. This method is not as sensitive for the 
14 
nicotinic acid analogs of the pyridine nucleotides (101)0 
Methods for separation of pyridine nucleotides by either ion ex-
change or paper chromatography a.re well known. Preiss and Handler (47, 
48) were among the first to use such methods and found that seven parts 
of 95 percent ethanol and three parts ammonium acetate, pH 5.0, was 
particularly useful as a solvent system for separation on paper. As 
will be described later, n-butanol:glacial acetic acid:water in a 
ratio of 4:1:2 also proves to be a successful method for separation of ' . 
the pyridine nueleotideso 
Radioisotopes can also be used with conjunction of evolution of 
14co2o Pastan and his coworkers (107) have described a method whereby 
6-phosphogluoose debydrogenase is used with 14c-6-phosphogluoonate and 
the amount of 14co2 produced is-proportional to the NADP+ concentration. 
If glutathione reductase and oxidized glutathione are also included, 
NADPH is oxidized to NADP4,which is then measured by the same assay 
-12 + system. Sensitivity is in the range of 10 moles NADP or NADPH. 
The last method involves using two enzymes coupled together with 
all substrates of the respective reactions in excess except the nucleo-:-
tide in question.. Low:ry ~ &• (108) were the first to use this 
technique. NADPH or NADP could be measured with the glutamic acid 
debydrogenase (L-glutamate:NADP oxidoreductase EC 1 .. 4o1o3) reaction 
coupled with the oxidation of glucose-6-phosphate to 6-phosphogluconate 
debydrogenase. As mentioned previously all substrates and enzymes were 
present in excess except of course the nucleotideso Again the un-
desired nucleotide could be previously.destroyed by adjusting the pH. 
After the reactions had been incubated several minutes in order to get 
an accumulation of 6-phosphogluconate proportional to tp.e original 
15 
nucleotide present, the concentration of this product was determined 
using 6-phosphoglu.conate dehydrogenase in an excess of NADP+ and 
mea.su.ring the fluorescence of NADPH., NAD+ and NADH can be assessed 
the same way using NAD+ glutamate dehydrogenase (L-glutamate:NAD oxido-
reductase EC 1o4o1o2) forming glutamate fromo(-ketoglutarate coupled 
with lactate dehydrogenase to form pyruvateo After incubation to allow 
accumulation of pyru.vate, the product is measured with lactate dehydro-
genase in the presence of excess NADH and the production of NAD+ is fol-
lowed fluo:rometricallyo Sensi.tivi ty as low as 10-9 M can be obtained 
if careful technique is usedo Other coupled enzymes can be used in 
place of those described and seem to work just as well (109) .. 
Biological Degradation of Pyridine Nucleotides 
Pyridine nucleotide destru.otion in mammalian liver tissue was 
observed early according to the literature (2, 6, 105» 106), and also 
in other organisms including microo~ganisms (86, 107), castor beans 
(113), and sweet almond extracts (21, 114)0 However, the responsible 
' ' 
enzymes were characterized only recently. 
One of the first enzymes d_iscovered was NAD+ pyrophosphatase which 
splits the pyrophosphate bond between the two ribose moieties producing 
niootinamide mononuoleotide and a.denylic acid from NAD+ while NMN and 
2v,5v-diphoephoadenosine a.re the products of NADP+ hyd:rolysisQ This 
enzyme has been observed in potatoes (115), kidney (116), and sweet 
almonds (117), while Prote'I!! yulgar1!! contains a "heat a.ctiva.ted" 
enzyme which carries out the same reaction with NAD+ and NADH (118)0 
Kidney and liver of rabbit and swin.e ( 119, 120) . converts NADF""" ·to 
N.AD+ o This aoti vity has a.lso been observ·ed with preparations of milk 
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alkaline phosphatase (121) and prostate phosphatase (122)0 Snake venom 
phosphatase along with the phosphatase of human or bull semen (123) and 
the 3i nucleotidase of barley (124) can attack the 3' and 5' nucleo-
tides but not the third phosphate of NADP+ attached to the ribose 
moiety of adenosine (32)o 
Takadiesterase contains a deaminase which converts the adenosine 
moiety to the inosinic acid analog of NAD+ called deamino NAD+ (122). 
While neither NADP+ or 2'-adenylic acid is attacked by this enzyme, 
3~-adenylic acid is, thus providing more evidence for a phosphate 
attached to the 2' carbon of ribose. 
NAD+ pyrophosphorylase catalyzes the reversible decomposition of 
NAD+ to NMN and ATP (125). Preiss and Handler reported that this 
enzyme also catalyzes the reverse reaction yielding NAD+ (48); however, 
they found that NaMN is a better substrate for the reverse reaction 
than is NMN. 
The degradative enzyme which has been studied in greater detail 
is diphosphopyridine nucleotidase (NADase) which forms free nicotin-
amide from both NADP+ and NAD+ but not from nicotinamide riboside (126, 
127)0 Kornberg reported that NMN is also split by this enzyme pre-
pared from rat brain (116) and this has been confirmed by Leder and 
Handler (93)o Spleen NADase, however, will not attack either NMN or 
nicotinamide riboside (128)Q 
Although NADase is inhibited by a high concentration of nicotin-
a.mide (129), NAD+ is not resynthesized from the split products even 
with a high concentration of nicotinamide or ARPPR, the other product 
of NAD+ degradation, Therefore a simple mass law effect will not 
explain the inhibition of NADase by niootinamide. 
Neurospora NADase, although possessing the same specificity as 
spleen NADase, is not inhibited by nicotinamide (130). Further.more, 
the enzyme is particularly abundant when the organism is grown on a 
zinc deficient medium (131). 
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It was found by Zatman and his coworkers (128) that nicotinamide 
could act as a noncompetitive inhibitor of NADase and furthermore, they 
observed nicotinamide-14c could exchange with the nicotinamide moiety 
of NAD+o This led to the theory that nicotinamide may be competing 
with H2o for the ARPPR-enzyme complex and this theory was given addi-
tional support when it was found that analogs of nicotinamide could 
replace nicotinamide, forming analogs of NAD+ (132). This phenomena 
does not occur with Neurospora NADase. 
Since this time, many analogs have·been prepared by the NADase 
exchange reaction (133-138) and many of these analogs have ,replaced 
NAD+ in i!!, vitro systems (134, 135, 139, 140). This does not mean 
that the nicotinamide moiety is without significance since most of 
these analogs are not as efficient as NAD+ itself in these reactions. 
Des-NAD+ and the 3-acetylpyridine analog are the two most widely known 
of these analogs. Des-N4.J)+ has been shown to be an intermediate in 
NAD+ biosynthesis (47, 48, 141) while APNAD+ has been used in trans-
hydrogenase assays (139, 142) and in the quantitative determination 
of glutamate (139). 
A specific NADPase has also been observed in erythrocytes (143-
145). The partial purification of both NADase and NADPaae has been 
reported and it was observed that while niootinio acid inhibits both 
enzymes f1•om this tissue (129), niootinio a.oid does not e:f'feotively 
i:nhibit NADase from other tissues (145). 
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The function of NADase in the organism is still unclear (146); 
however, because it releases free nicotinamide, it may be that this is 
part of a salvage mechanism for regulating the level of NAD+. Nicotin-
amide deamidase has been found in a number of organisms, and recently 
this enzyme has been found in rat liver by Petrack ~ .iib.• (147) who 
later showed that it may exist i:.a. ~ in an inhibited state (148). 
They concluded from this that deamination of nicotinamide is the first 
step in the biosynthesis of NAD+ ~ the Preiss, Handler pathway (48). 
The significance of this will be discussed later. 
Enzymatic cleavage of the riboside linkage has been reported in 
human and bovine erythrocytes (149, 150). While the enzyme is sensi-
tive to nicotinamide in the crude state, partial purification of the 
enzyme relieves the sensitivity. The responsible factor for its sensi-
tivity appears to be ergothionine (2-thiolhistidine) but the mechanism 
by which it functions has not been elucidated as yet. Ergothionine 
also produces sensitivity of Neurospora NADase promoting an exchange 
reaction of nicotinamide-14c into NAD+ (150). 
Biosynthesis of Pyridine Nucleotides 
The earliest indication of NAD+ biosynthesis was noted by Harden 
(151), who observed that the rate of degradation of NAD+ was much 
faster in the absence of active fermentation than in the presence of 
fermentation. Later Lennerstrand (152, 153) reported that "apozymase" 
+ destroyed NAD when not supplemented with the requirements necessary 
for fermentation. In contrast, when nicotinamide, adenylic acid, in-
organic phosphate, glucose, and hexose diphosphate were present with 
the 99apozymase" preparation, partial resynthesis of NAD+ could be ob-
served~ As would be expected, synthesis was greatest when all were 
added simultaneously and when NAD+ was added in addition to the com-
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ponents, the rate of destruction was reduced even more. Fluoride would 
completely inhibit synthesis of NAD+ from either nicotinamide and 
adenylic acid or from nicotinamide and adenosine. 
In 1937, nicotinic acid and nicotinamide were found to cure 
pellagra in man (154, 155) and black tongue in dog (156). Subsequently, 
many attempts were made to correlate the concentration of pyridine 
nucleotides and the physiological status in man and animals. With 
these studies, it was found that "cozymase," assayed as "V" factor, had 
a concentration level in liver and muscle, about 30 percent lower in 
those subjects which had the disease than in the normal subjects (157-
159). On the contrary, Kohn and his coworkers (91) found that the 
nucleotide concentration in erythrocytes did not vary with the 
physiological state of the animal. 
Although there were no significant differences in NAD+ concentra-
tion in erythrocytes of animals possessing pellegra, it was found that 1"":. 
when experimental animals ingested large amounts of nicotinic acid, an 
elevation of about two fold in the concentration of NAD+ in this tissue 
was observed (160-164). This was confirmed with .!,a vitro studies (162, 
164) but little or no synthesis in erythrocytes was observed with nico-
tinamideo Examples of these data were that of Leifer~ &Q (165) who 
noted that when nicotinic acid-14c was incubated with defibrinated 
human blood, radioactivity was incorporated into the cells which could 
not be washed out, while on the other hand, when nicotinamide-14c was 
incubated with the same tissue, the radioactivity which was incorporated 
was easily washed out. In mouse erythrocytes, however, both compounds 
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gave rise to non-extractable radioactivity. 
The first indication of formation of NAD+ on the enzymatic level 
ca.~e from the laboratory of Kornberg (125, 166) in 1948 when he and his 
colleagues could show the production of NAD+ and PPi with a yeast 
enzyme supplemented with ATP and :NMN. The reaction is freely reversible 
and when NAD+ and radioactive PPi are incubated with the enzyme, ATP 
takes up the radioactivity with the two terminal phosphate coming from 
the PPi (167). + The NAD molecule on the other hand, failed to take up 
any of the phosphate. 
Leder and Handler (93) reported the accumulation of NMN when 
erythrocytes were incubated with large amounts of glucose and nicotin-
amideo When these data were compared to the above mentioned observa-
tion of the presence of a large amount of NAD+ pyrophosphorylase and 
the reversibility of this enzyme was considered a possible pathway for 
N.AD+ biosynthesis was provided. Preiss and Handler (103) investigated 
this possibility and did indeed find a NMN phosphorylase present in 
human erythrocytes which formed NMN.from nicotinamide and 5-phospho-
ribosyl-1-pyrophosphate., However, the Km for nicotinamide was not 
physiological, being in the order of about 0.1 M. This high K taken .. m 
along with the fact that erythrocytes obtain a low NAD+ pyrophos-
phorylase activity (103, 168) .and that erythrocytes are capable of 
synthesizing NAD+ at low levels of nicotinic acid but not nicotinamide 
(164, 169) discouraged this idea and led to the possibility of an 
alternate pathwayo 
In a preliminary report (170) and later in a detailed publication 
(47, 48), Preiss and Handler elucid~ted the biosynthetic pathway of 
NAD+ from nicotinic acid, establishing niootinic acid mononucleotide 
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and desamido-NAD+ a.s interipediates (Figu.re 2)o 
The enzyme NaMN pyrophoryla.se which catalyzes the formation of 
Na.MN from nicotinic acid was partially purified from erythrocytes and 
later purified to a greater extent from beef liver acetone powder 
(171)0 It was found that the enzyme required nicotinic acid, PRPP, 
Mg++, ATP and orthophosphate. This system of enzymes had every appear-
ance of being the primary pathway for NAD+ biosynthesis in that all of 
the responsible enzymes showed physiological Kms and velocity. In addi-
tion this pathway seemed to be present in a number of organisms be-
sides the mammalian system including ~o ..£21! (52), Mycobacterium (53) 
and yeast (47, 172). Thus for a matter of two or three years, the main 
pathway of biosynthesis of NAD+ was thought to have been elucidated. 
For several years tryptophan was known to substitute for niacin in 
the diet (173). Additional studies revealed that addition of trypto-
phan to the diet resulted in an increase in the excretion of Ni-methyl-
nicotinamide in the urine (174, 175). A number of nutritional studies 
have shown that tryptophan can replace niacin in the rat, dog, rabbit, 
pig, monkey, chick, duck, and several other mammals and bir~s (176, 
177)0 The studies with mutant strains of !o crassa and with rat ~ave 
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led to recognition of the fact that kynuren1ne (178), 3-hydro:xy-
kynurenine (179), and 3-hydro:xyanthranilic acid (179-181) are inter-
mediates in the conversion of tryptophan to niacin. Direct evideµce 
for the metabolic relationship between tryptophan and niacin has come 
from isotope experiments in which labeled tryptophan or 3-hydro:xy-
anthranilic acid was given to the rat and the niacin from the tissues 
and urine a.nalyzedo The results indicated that position 3 of the in-
dole ring becomes the carbo:xyl carbon of niacin (182-185) and that the 
Figure 2. 
Pathways of NAD+ Biosynthesis From Tryptophan, 









nitrogen of the indole ring is converted to the pyridine ring nitrogen 
of niacin (185, 186). 
·In 1951, Preist~~. (187) reported that a soluble enzyme system 
from liver and kidney catalyzes the conversion of 3-hydro:xyanthranilic 
acid to quinolinic acid. Several investigators subsequently showed 
that the primary product of oxygenation reaction was 2-amino-3-acroleyl-
fumaric acid and the cyolization of the latter resulted in the formation 
of quinolinic acid (QA) (188-191). The latter reaction appeared to be 
a spontaneous reaction not requiring an enzyme. However, quinolinic 
acid had up until this time been considered a by-product of tryptophan 
metabolism rather than an intermediate in niacin biosynthesis since the 
compound is a very poor growth factor in the rat and Neurospora (192). 
In the several mammalian liver preparations studied by Mehler and May 
(193), picolinic carbo:xylase was the only enzyme found to react with 
2-amino-3-acroleylfumaric acid. The reaction produced picolinic acid 
and did not result in the formation of niacin. 
In 1963, Nishizuka and Hayashi (192) obtained a system from rat 
liver which converted 3-hydro:xyanthranilic acid to niacin ribonucleo-
tide (nicotinic acid mononucleotide) in the presence of PBPP. Evidence 
was presented that free nicotinic acid is not an intermediate in this 
pathway ·which is now known as the NAJt pci.t}iway of tryptophan metabolism 
(Figure 2). The niacin. ribonucleotide produced is converted to des-NAD+ 
in the presence of ATP by a pyrophosphorylase and the latter is then 
amidated to NAD+ in the presence of glutamine and ATP by NAD+ synthe-
tase ~ the Preiss-Handler pathway (47, 48). 
Subsequently, the same reaction was shown to take place in!• coli 
(194), a number of lliycobacteria (195) and plants and fungi (194, 196). 
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Gholson!,!& .. (197) were able to isolate the enzyme converting QA to 
NaMN proving that it was a separate enzyme from NaMN pyrophosphorylase. · 
'!'hey also showed that the pathway had kinetic properties which allowed 
suffi~ient NAD+ biosynthesis to account.for the pyridine nucleotides 
needed by the body. In addition, it was found that this enzyme is 
about 20 times as active as the NaMN pyrophosphorylase and thus they 
concluded that this was the main pathway for NAD+ biosynthesis. 
While the above discussion reveals two pathways for NAD+ biosyn-
thesis, it is known that still another must exist. For example, 
Andreoli et al. (194) ha.v·e shown the PBPP dependent formation of NaMN --
from quinolinate in!• .£2.!i and this reaction has also been shown to 
occur in plants (54)Q Since neither!• .£21.1. (198) nor plants (199) are 
able to convert tryptophan to niacin it must be concluded that in these 
organisms quinolinate arises by a mechanism other than the degradation 
of tryptopha.nQ 
'l'he details of the third pathway for the synthesis of NAD ~ Na.MN 
have not been elucidated as yet. Ortega and Brown (200) have shown 
that nicotinic acid could be synthesized in vivo in E.coli, from a 
. -- --
3-carbon compound (glycerol or a closely related compound) plus a 4-
carbon dicarboxylic acid. Other studies with Bacillus subtilis (198), 
and!• tuberculosis (201) indicated that both aspartate and glycerol 
could serve as precursors of nicotinic acid in these organisms. Ahmad 
and Moat (202) presented evidence that under anaerobic conditionsj 
yeasts incorporate radioactivity from uniformly labeled aspartate-14c 
and glutamate-14c suggesting that an alternative pathway other than the 
tryptophan pathway also operates in yeast under these conditions. 
Furthermore, evidence was shown which established quinolinic acid as a 
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precursor of des-NAD+ under either aerobic or anaerobic conditions in 
this organism. Working with Clostridium butylicum, Isquith and Moat 
(203) found that crude extracts were able to incorporate 14c from uni-
formly labeled aspartate and glycerol in the same manner as did growing 
cultures. However, upon fractionation of the extract, only aspartate, 
acetyl Co A,and formate gave rise to an increase in nicotinic acid 
production. Furthermore, quinolinate was shown to be intermediate in 
this pathway. 
Chandler ~l!d.· (204) reported that cell free preparations of 
E.coli have been shown to convert aspartate-14c and succinate-14c to --
quinolinate-14c. Degradation of the product formed from uniformly 
labeled aspartate-14c showed a labeling pattern consistent with a 
direct incorporation of aspartate into carbons 2, 3, 7 and 8 of quino-
linate. Variation of the concentration of a niacin requiring mutant 
of];. £211 produced changes in the extent of incorporation of succinate-
14c into quinolinate-14c by cell free preparations of this organism 
suggesting that the pathway of quinolinate biosynthesis. is under 
repression control. 
Thus, the pathway of niacin mononucleotide biosynthesis may pro-
ceed from at least three different routes. Under various circumstances 
the same organism may use one particular pathway although the potential 
for one or both of the other pathways may exist. It is seen, there-
fore, that the control and the level of each individual pathway is very 
complicated and the details to date remain obscure. 
Regulation of the Biosynthesis of Pyridine Nucleotides 
Regulation~ ATP 
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Since there exist at least three routes for pyridine nucleotide 
synthesis, there should be some means of control whereby the different 
pathways are regulatedo Imsande and Pardee (205) made one study of this 
regulation using !o .221.i• They found that a repression-derepression 
mechanism existed with the NA~ Na.MN~ NAD+ pathway. This con-
cluaion was based on the finding that if the concentration of nicotinic 
acid is below 10-6 M, the activity of nicotinic acid mononuoleotide 
pyrophosphorylase is increased over 5-fold. It was also concluded 
that this enzyme is rate limiting in the biosynthesis of NAD+ as would 
be expeotedo When a culture of the organism which had been grown in 
the derepressed state was incubated with a high concentration of niacin 
the pyrophosphorylase activity reverted to that of the repressed state. 
Salmonella t:ypherium and possibly Serratia marcesens, two organisms 
very similar genetically to !o £21.i, also exhibited this phenomenon. 
Contrastingly, this repression is apparently absent in most other 
organisms including yeast, tetrahymena, and the rat (206)~ 
Adenosine triphosphate apparently plays some role in this regula-
tion. In another study using Bacillus subtilis (207), it was found 
that ATP is the limiting substrate for nicotinic acid mononucleotide 
pyrophosphorylaseo This was evidenced by the fact that while the 
apparent K for ATP was 4 x 10-4 M the intracellular concentration 
m 
was in the neighborhood of 5 - 10 x 10-5 M. Conditions that increased 
the intracellular concentration of ATP, while inhibiting all growth, 
resulted in no decrease in the rate of pyridine nucleotide formation. 
Although this constituted no proof of regulation of NAD+ biosynthesis 
by ATP, it certainly suggested that ATP may be involved in this regula-
tion. 
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Upon partial purification of the enzyme from ~o subtilis (208) it 
was found. that ATP could 1,e replaced by other triphosphate nucleotides 
with GTP replacing ATP the best. Even tripolyphosphate substituted to 
some extent, being approximately 30 percent as efficient as ATP when 
added at high concentrations, When the enzyme was treated with urea, 
binding of ATP was inhibited, thus providing evidence that there is a 
separate binding site for ATP on the enzyme. It was also found t~at 
ATP is required for activity and that it is converted to ADP during 
the process of the reactiono A two step reaction involving an ADP or 
Pi and either of the two atoms which comprise the ribosyl-niacin bond 
must be ruled out since the pyrophosphate moiety of PRPP is of the o(-
configuration, whereas the ribosyl-nicotinamide bond of NAD+ is of the 
~-configuration. 
While considering the mechanism of control in the~. subtilis 
organism it should be noted that although ATP may play a significant 
role in regulation of NAD+ biosynthesis from niacin, NAD+ also arises 
. + lli the QA to NAD pathwayo In this connection, Gholson and Kori (209) 
found that the synthesis of NaMN from QA is under a repression-derepres-
sion control in this organism~ 
Imsande and Handler (171) reported that ATP stimulates the activity 
of beef liver NaMN pyrophosphorylaseo More recently Nakamura.~ !!-1• 
(210) have suggested that ATP may play the role of an allosteric modi-
fier of NaMN pyrophosphorylase. These workers reported that in the 
~bsence of ATP, Na.MN pyrophosphorylase dissociates into subunits which 
have nicotinate-ribonucleos,idas~ activity. These subunits reassociate 
in the presence of ATP to form NaMN pyrophosphorylase which has no 
ribonucleotidase activityo They concluded that this was a pot~nt 
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mechanism for the regulation of NAD+ biosynthesis. In the presence of 
ATP,.NAD+ would be synthesized from niacin and in the absence of ATP, 
.the ~stem would degrade Na.MN to nicotinic acid by the ribonucleotidase 
activity •. · The study of this phenomenon is .an important part of this 
thesis. 
Effect of Hormones 
In 1956 Kaplan.!!!:!• (211) found that when nicotinamide (250-500 
mg/k.g body weight) was injected into rats, a large increase in the con-
centration of hepatic pyridine nucleotides resulted. The increase is 
largely in the form of oxidized NAD+ and is associated with a parallel 
rise of liver acid-soluble adenine, nicotinamide, ribose, and phos-
phate (212). No changes of concentrations of nucleic acids, or of 5'-
adenylic acid, ADP and ATP have been detected. These results show that 
formation of the newly synthesized pyridine coenzyme does not occur at 
the expense of the various components already present.in the liver. 
Greengard ,!! !:!• (214) stated that in hypophysectomized rats this 
effect is more pronounced and lasts for a longer period of time. For 
example, 30 hours following nicotinamide administration, the level of 
NAD+ in normal ,animals had returned to the endogenous level of about 
45o·µg .NAD+ per gm wet weight of tissue, whereas that in the hypo-
physectomized animals remained as high as 3000 µ.g/gm. Apart f;om the 
liver, only the 'kidney showed more than a doubling of N.A:Q+ content 
upon the administration of nicotinamide, but even this was not as pro-
nounced. When the experiment was repeated with nicotinic ~cid or 
tryptophan, some increase in the·level of NAD+ occurred, but'not nearly 
to the extent of the increase following nicotinamide administration. 
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Experiments were carried out to determine which of the known 
anterior pituitary hormones might be involved in this effect by testing 
their ability to reverse the effect of hypophysectomy on the change in 
the level of liver NAD+ which occurs following nicotinamide administra-
tion. ACTH and cortisone acetate, reversed this effect to some extent. 
The response of. the NAD+ level to nicotinamide administration was also 
affected by adrenalectomy, but not as greatly as by hypophy*3ectomy 
(215). These results suggested to the authors that this effect may be 
mediated through the pituitary-adrenal system. Additional evidence 
supporting the view that this is a fairly specific hormonal .effect is 
that parathyroid extracts cause bone resorption but do not increase 
the nicotinamide coenzyme level following injection of nicotinamide 
( 216). 
The incre~se in the concentration of liver NAD+ due to nicotin-
amide injections can be prolonged by the administration. of chlorproma-
zine or reserpine as shown by Burton.!!~· (217). Both chlorpromazine 
and reserpine, as many authors have shown (218), have marked effects 
on the pituitary-adrenal axis. Greengard and Quinn (219) investigated 
this effect further. They confirmed earlier work that ACTH could 
~everse the effect of nicotinamide in hypophysectomized rats. Taking 
all of the evidence together, it seemed quite possible that the effect 
of chlorpromazine and reserpine on liver NAD+ may be the result of· 
these drugs causing a decreased pituitary activity. They found a 
.Paralleled correlation existed between the seda,tive action of these 
ai-u.gs and increased NAD+ levels upon challenging with both nicotinamide 
and tranquilizer, thus further confirming that decreased pituitary 
activity is associated with NAD+ biosynthesis. 
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Several types of tumors have been found to contain much lower 
levels of NAD+ and other pyridine nucleotides than corresponding normal 
tissues (220-222). Shimoyama ~ .!l• (223) found that 3-hydro:xyanthra-
nilic acid oxidase activity is greatly reduced in tumor tissue. QA 
phosphoribosyl-transferase and Na.MN pyrophosphorylase were also 
greatly reduced or absent in tumor cells. These results are in agree-
ment with the work of Clark!,!!!• (224) who found that treating with 
various carcinogens such.as 4-methylamino-3-methylazobenzene and 4-
dimethylamine-4'-fluoroazobenzene, even in precancerous conditions, 
causes a definite over all decrease in pyridine nucleotides. To date 
the mechanism of this phenomenon has not been worked out. 
Pyridine Nucleotide Cycle 
According to the Preiss Handler pathway (47, 48) nicotinic acid 
is an intermediate in NAD+ biosynthesis. However, niootina.rnide appears 
to be a much more efficient precursor of hepatic NAD+ than niootinio 
acid, when these two compounds are injected intraperitoneally (211, 212). 
Several workers (145, 225, 228) have investigated this apparent para-
dox. When nicotinamide was injected, the formation of des-NAD+ was 
increased in conjunction with NAD+ and then, as would be expected of 
an intermediate, the concentration of des-NAD+ falls back to normal 
while that of N.AD+ remains high (141). Also, 45 minutes following 
intraperitoneal injection of radioactive nicotinamide, the specific 
activity of hepatic des-NAD+ was approximately twice as high .as NAD+ 
itselfo 
Experimentation with low doses of nicotinic acid revealed that 
when nicotinic acid is injected at a dose level of 50 mg/kg body weight, 
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the amount of NAD+ formed approaches that obtained from 500 mg/kg of 
nicotinamide and is substantially higher than the amount produced by 
50 mg/kg of nicotinamide (226). Thus at doses lower than 50 mg/kg, 
nicotinic acid produces a greater synthesis of NAD+ than nicotinamide, 
while at doses of 100 to 500 mg/kg the relative effectiveness of these 
two compounds is rever~ed. The accumulation of the des-NAD+ in the 
nicotinic acid injected animals occurs only .at a dose of 50 mg/kg, the 
maximal dose for NAD+ biosynthesis, while in the animals given injec-
tions of nicotinamide, accumulation occurs only at doses of 200 mg/kg 
or above (141). 
A study by Minard and Hahn (227) on the relative efficiency of 
precursors of NAD+ as related to the rate of biosynthesis showed that 
with injections of the order of 50 mg/kg of nicotinic acid, nicotin-
amide, Na.MN, and NAD+ that Na.MN gave the fastest rate of bi.osynthesis. 
Therefore, these authors suggested that the :rate limiting step in this 
biosynthetic pathway is the formation of Na.MN. Thus the evidence indi-
cates that even though nicotinamide in high concentrations leads to a 
greatly incr~ased biosynthesis of NAD+, it appears that this synthesis 
occurs through the Preiss-Handler pathway (48). 
Ni~otinamide has a significantly longer half-life in hepatic tis-
sue than nicotinic acid (227). When both compounds were injected at a 
conceritration of 500 mg/kg, the nicotinamide disappeared from the liver 
with a half-life of 4.4 hours whereas the half-life of nicotinic acid 
was only 1.0 hour. This difference in rate of disappearance was also 
observed in whole blood. Excretion of nicotinamide-14c was mainly· in 
the unchanged form when these compounds were given at thi~ high dosage 
level. However, when these compounds were injected at a low level, 
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five mg/kg, the radioactivity was excreted primarily in the form of 
metabolites. Moreover, .the rate of excretion of radioactivity was 
approximately the same for both forms of the vitamin. Although the 
percentage of administered nicotinic acid and nicotinamide excreted as 
metabolites was lower with a 500 mg/kg dose than with a five mg/kg 
dose, the absolute amount of metabolites derived from the five mg/kg 
dose was lower .. 
It should be brought out in this connection that nicotinic acid 
at high concentration (225, 227), that is 500 mg/kg, either with nico-
tinamide or without, shows an inhibitory action on the biosynthesis of 
NAD+. The mechanism of this inhibition is not understood. The short 
half-life of nicotinio acid in liver and the inhibition of NAD+ bio-
synthesis by high concentrations of nicotinic acid may explain the 
relatively low efficiency of this compound as a precursor of NAD+. 
Nicotinamide could slowly be deaminated by the liver niootinamidase 
(147) keeping the concentration of the nicotinic acid low enough to 
prevent inhibition and allow NAD+ biosynthesis to be carried on. 
In contrast to the results discussed above, Jjichi ,!.! ~. (228) 
found that following pulse-labeling with nicotinic acid-14c, nicotin-
amide-14c, or quinolinic acid-14c, niootinamide disappeared quite 
rapidly from the liver. For instance, when nicotinamide-14c (78 
n,:unoles)was injected into the portal vein of mice weighing 25 to 30 g, 
a large portion of the radioactivity disappeared rapidly from the liver 
during the first three minutes, and less than 10 percent of the total 
radioactivity in the liver appeared to increase slightly. In contrast, 
the radioactivity of injected nicotinic acid remained in the liver in 
"1UCh larger quantities. More than 20 percent of the total radioactivity 
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was recovered from the liver even after four hours~ When quinolinic 
acid-14c was injected by a similar procedure, less than 10 percent of 
the radioactivity was recovered in the liver even 20 seconds after the 
injection, showing that QA cannot penetrate the cello When an analysis 
of the nicotinic acid-14c metabolites was made, it was found that 
nicotinic acid-14c disappeared quite rapidly in the liver. After three 
minutes less than five percent of the radioactivity was recovered as 
nicotinic acid-14c, and by 10 minutes it had disappeared almost com-
pletely. The rapid disappearance of nicotinic acia..-14c was accompanied 
by the appearance of NaMN-14c and des-NAD+-14c. 
In contrast to nicotinic acid-14c, there was a small but definite 
incorporation of nieotinamide-14c immediately after the injection but 
there occurred no increase of NAD+-14c during the first 10 minute 
period. After several hours, NAD+-14c in the liver started to increase 
slightly. No other radioactive nicotinic acid derivatives accumulated 
to any appreciable extent. 
As already noted, when small doses of nicotinic acid were in-
jected, nicotinic acid is a better stimulator than nicotinamide in in-
creasing the NAD+ content of the liver while at large doses, the effect 
is reversed. These authors injected a large quantity of nicotinamide-
14c directly into the portal vein and then removed the livers and 
analyzed them at various time intervals. The radioactivity decreased 
from the liver rapidly during the first hour; however, an increase of 
radioactivity began after one or two hours which was associated with a 
net increase of NAD+. This suggested that the nicotinamide was rapidly 
excreted from the liver except for the small amount that appeared to be 
transformed into NAD+ ~ nicotinamide mononucleotide adenyl transferase, 
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and then returned to the liver after an interval of one or two hours 
presumably in the form in which it can be used in the synthesis of NAD+. 
Survey of the distribution of radioactivity after intraperitoneal 
injection of a large dose of nicotinamide-14c showed that although 
there was a large proportion excreted in the urine, as much as 20 per-
cent of the radioactivity was found in the gastrointestinal tract one 
hour after injection. The radioactivity in the tract then decreased to 
about one-third after four hours with a concomitant increase in liver 
NAD+. Preliminary analysis showed that 90 percent of this radioactivity 
was located in the contents of the tract rather than in the stomach or 
intestinal wall. When nicotinamide was injected intraperitoneally, as 
much as 50 percent of the injected radioactivity accumulated in the 
tract. Furthermore, an increase of radioactive nicotinic acid was ob-
served with a concomitant decrease of nicotinamide-14c during the four 
hours after injection. 
These authors suggest, in view of these experiments, that nico-
tinamide is rapidly excreted from the liver and is sent to the gastro-
intestinal tract where it is deaminated to niootinic acid. The nico-
tinio acid formed is returned to the liver where it is used in the bio-
synthesis of NAD+. 
Which, if either, of the two theories mentioned above is correct 
remains to be seene It should be pointed out that the liver nicotin-
amidase has a high Km but this would still release enough nicotinic 
acid to allow maximum NAD+ biosynthesis and at the same time keep the 
concentration low enough to prevent the inhibition that is associated 
with a high concentration of nicotinic acid. 
Considering these facts and the following information Gholson (229) 
proposed a pyridine nucleotide cycle (Figure 2). This theory is based 
on the following factso Tryptophan serves as the~ !!2!Q. precursor of 
QA in mammals (193, 197) and a number of other organisms. In higher 
plants (230) and some bacterial species, QA is synthesized from gly-
cerol and asparate (34, 194, 198-204) by an unknown series of reactionso 
Once at the level of Na.MN, the biosynthesis pathway appears to be.!!! 
the so called Preiss-Handler pathway (48). NAD+ is split by a number 
of enzymes, the most common being the glycohydrolase type which splits 
the NAD+ molecule into niootinamide and ARPPR. Nicotinamide released 
by NADase activity may be reutilized by deamidation to nicotinic acid 
(147). Greengard ,!! .!!• have reported that nicotinamide deamidase is 
in an inhibited state ,!a .!1!2. and upon hypophysectomy, the activity of 
this enzyme is greatly elevated (231). If the effect of hypophysectomy 
on NAD+ metabolism is to increase nicotinamide deamidase activity, then 
an increase in the activity of this cycle could explain the fact that 
synthesis of NAD+ from nicotinic acid and tryptophan is also increased 
by hypophysectomy. 
Other evidence for the existence of this cycle is provided by the 
observation that when nicotinamide-14c-15N is injected into rats, the 
carbo:x:yl group is almost undiluted while there is considerable dilu-
tion of the amide nitrogen in hepatic NAD+ (232). Data consistent 
with the operation of this cycle in plants have been reported by 
Waller et alo (233)0 -- . 
Since the regulation of the various pathways of NAD+ biosynthesis 
appears to be varied and complex, this thesis will deal with a small 
phase of this topico The enzyme, nicotinic acid mononucleotide pyro-
phosphorylase, is believed to be one of the regulatory sites of NAD+ 
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biosynthesis from nicotinic acid (205-208, 210). Therefore, this thesis 
will describe work which shows that this enzyme displays unusual prop-, 




The assay for Na:MN pyrophosphorylase activity was a modification 
of the system of Imsande and Handler (171)0 The standard incubation 
mixture included in a total volume of Oo15 ml the following: nicotinic 
acid, 00067 mM; PRPP, 1.33 mM; ATP, 00667 mM; MgC12, 3o33 mM; phosphate 
buffer, pH 7e5, .26.6 mM; and approximately 0.25 units of enzyme. 
When asse.ys of c:ru.de extracts were carried out, Oo4 pmole of NaF was 
included in order to inhibit ATPase activity. The incubation mixtures 
were then allowed to react for two hours at 37° C and were deproteinized 
by heating in a boiling water bath for one minuteo A 50 pl aliqu.ot was 
then spotted on Wha tman #1 chromatography paper a.n.d developed in a 
descending manner for three to four hours in n-butanol:glacial acetic 
acid:water (4i1g2 v/v/v). The product is well separated from nicotinic 
acid with this system and stays on or close to the origin; therefore, 
the area surrounding the origin was routinely cut out, put in a 
scintillation solution containing four g PPO and 0.2 g POPOP per l of 
sulfur-free toluene, and counted on a Packard Instrument Company tri-
oarb scintillation spectrophotometer.for a minimum of five minutes. A 
unit of' enzyme activity is that amount which will catalyze the forma-
tion of one mpmole of Na.MN per hour. Protein was determined by the 
Lowry modification of the Folin-Ciocalteau procedure using bovine 
38 
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serum albumin as a standard (234). 
NaMN was identified by comparing its Rf with that of known NaMN in 
two different solvent systems: one M ammonium acetate:95 percent 
ethanol (3:7 v/v) adjusted to pH 5.0 with HCl, and the previously men-
tioned system of n-butanol:acetic acid:water. When the chromatograms 
were developed in the latter system for 14-16 hours, the NaMN migrated 
off the origin with an Rf of 0.17. This system quite easily separated 
NaMN and des-NAD+ which had an Rf of 0.05. 
In order to determine the amount of ATP converted to ADP, a slight 
modification of the normal assay was used. In a total volume of 0.75 
ml, the following were added: nicotinic acid-14c, 0.0067 mM; MgC12, 
3.33 mM; phosphate buffer, pH 7.5, 26.6 mM; ATP-14c, 0.21 mM; PRPP, 
Oo27 mM; and approximately three to four units of enzyme. The system 
was allowed to incubate two hours at 37° C after which time the reac-
tion was stopped by immediately freezing in dry ice. The products were 
separated by placing the contents of the incubation mixture, after 
diluting to 50 ml, over a Dowex-1-formate column 0.5 x 7 cm2• Non-
radioactive carrier nicotinic acid and ADP (one and 0.5 umoles, respec-
tively) were added in order to detect them as they were eluted off of 
the column by reading the absorbance at 260 llW-· The column was then 
eluted with six ml of 0.1 N HCOOH, eight ml of 0.25 N HCOOH, 12 ml of 
1.0 N HCOOH, and finally with 30 ml of 4.0 N HCOOH. Using this pro-
cedure, it was possible to determine both the amount of Na.MN formed and 
the amount of ATP converted to ADP simultaneously. After th~ products 
were separated the fractions ~ne ml each) were collected and aliquots 
were spotted on paper and counted on a Packard tri-carb scintillation 
counter as described above. 
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The purification of Na.MN pyrophosphorylase was also a slight modi-
fi·cation of Imsande and Handler's system ( 171). The purification pro-
cedure was as follows: 
Step 1• One hundred and twenty g of beef liver acetone powder 
was extracted at room temperature with 1200 ml of phosphate buffer, 
0.05 M, pH 7.5 for 30 minutes. The suspension was then centrifuged at 
10,000 x g for 20 minutes and the precipitate discarded. All subse-
o quent steps were performed at 0-4 c. 
Step g. Ammonium sulfate (238 g) was added to 1020 ml of the 
supernatant from the preceding step. This is approximately a 0-40 
percent fraction. The precipitate was collected by centrifugation at 
10,000 x g for 10 minutes and then taken up in 800 ml of 0.01 M phos-
phate buffer pH 7.5 containing 10-2 M mercaptoethanol. It was then 
dialyzed for four hours against 20 1 of water. The supernatant from 
the ammonium sulphate fractionation was discarded. 
Step .l• Sixteen ml of 0.4 N HCl was added to 830 ml of the 
dialyzed solution to bring the pH down to approximately 5.3. After 
stirring for one hour, the precipitate was centrifuged down and dis-
carded. The supernatant was then adjusted to pH 7.5 with 8.5 ml of 
one N KOHo 
Step .4. One hundred and eighty ml of calcium phosphate gel sus-
pension (30 mg/ml) was then added to the 820 ml of step 3. After 
stirring for 15 minutes, the suspension was centrifuged and the pre-
cipitate discarded. 
Beyond this step the enzyme became unstable; therefore, the prepa-
ration was routinely stored at -20° Cat this step. When assays were 
performed, small aliquots were taken and further purified. A summary 
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of purification through this step is shown in Table I. 
Step 2• A 25 ml aliquot of step 4 enzyme was dialyzed for seven 
hours against four 1 of water. , It was then placed on a DEAE cellulose 
column 1.8 x 12 cm2 which had been previously equilibrated in 0.015 M 
phosphate buffer pH 7.5. The enzyme was subsequently eluted from the 
column with a linear gradient consisting of two reservoirs containing 
130 ml each of 0.015 Mand 0.05 M phosphate buffer pH 7.5, respectively. 
After the gradient was completed, an additional 100 ml of the 0.05 M 
buffer was passed through in order to elute all of the enzyme off of 
-2 the column. All buffers contained 10 M mercaptoetha.nol. 
The fractions containing the enzyme were then combined and the 
enzyme was concentrated by adding ammonium sulfate (o-80 percent satura-
tion), centrifuged and taken up in two ml of 0.001 M phosphate buffer, 
pH 7.5. 
SteI? .2.• To each mg o.f protein obtained in step 5, three mg of 
. alumina Cr was added and the mixture stirred for ten minute.a. After 
centrifugation the supernatant was discarded •. Two ml of phosphate 
' -2 
buffer 0.05 M, pH 7 .5 containing 10 M mercaptoe.thanol, were then 
added to the precipitate and after an addit.ional ten minutes of 
stirring the suspension was again centrifuged •. Finally to the pre-, . 
cipitate from this centrifugation was added one ·ml of 0 •. 1 M phosphate 
-2 buffer pH 7.5 containing 10 M mercapt~ethanol, and after ten minutes 
of extraction the suspension was centrifuged and the gel discarded. 
The final specific activity varied with ea.oh preparation but normally 






SUMMARY OF PURIFICATION THROUGH THE 
CALCIUM PHOSPHATE STEP 
Volume Protein Units 
(ml) (mg) (total) 
1,020 42,432 61,812 
830 15,272 62,650 
820 5,945 56,170 










Nicotinic acid-7-14c obtained from Calbiochem was routinely puri-
fied before use by applying it on Whatman #1 chromatography paper and 
developing in n-butanol:acetic acid:water. The radioactive nicotinic 
acid was then eluted off the water and subsequently used in enzyme 
assays. 
The DEAE cellulose was routinely washed before use. The cycle 
used was essentially that given by Peterson and Sober (235). After 
washing, the resin was equilibrated in 0.015 M phosphate buffer, pH 
7.5 containing 10-2 M mercaptoethanol. 
Dowex.-1~formate was regenerated by washing with several volumes of 
one N HCl and then with four M ammonium formate until no more chloride 
ion could be detected coming off of the column. Finally the column was 
flushed thoroughly with deionized water before use. 
NaMN-7-14c was prepared in the following way. Eight ml of 
partially purified erythrocyte acetone powder extract was incubated 
seven hours at 37° C with the following in a total volume of 17 ml: 
.nicotinic acid-14c, 0.6 mM; MgC12, 8.1 mM; phosphate buffer pH 7.5, 
3.2 mM; ribose-5-phosphate, 2.7 mM; ATP, 3.1 mM. The reaction was 
stopped and deproteinized by heating in boiling water for two minutes. 
After centrifugation, the supernatant was applied to Whatman #1 chroma-
tography paper and developed in the ammonium acetate:ethanol solvent 
mentioned above. After determining the location of the radioactive 
Na.MN by a Nuclear Chicago Strip Scanner, the area was cut out and the 
Na.MN-7-14c eluted with water. After diluting this solution to 500 ml 
with water, it was applied to a Dowex-1-formate column (1.7 x 30 cm2) 
and eluted in a ·stepwise manner with 0.1 N HCOOH, 190 ml; 0.25 N HCOOH, 
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560 ml; 1o0 N HCOOH? 310 mlo The Na.MN-7-14c which was eluted in the 
1o0 N acid was concentrated to dryness by lyophili~ationo After taking 
up in a mi.nimum volume of water, the Na.MN-7-14-c was again applied to 
Whatman#1 chromatography paper and developed this time in butanol; 
14 · 
acetic acid:water (4:1:2 v/v/v)o The Na.MN-7- C was then eluted and 
was by this tim~ essentially free of all other radioactive components. 
After purification, i·t was then incubated with phosphodiesterase and 
acid phosphataseo Phosphodiesterase would not react thus ruling out 
the possibility of it being des-NAD+ 9 while acid phosphatase reacted 
with it producing nicotinic acid ribose-1-14co This plus the fact that 
its Rf compared favorably with that reported in the literature (192) 
. 14 
proved that it was Na.MN-7- C • 
. ATP-8-14c, obtained from Nuclear Chicago Coo 9 was purified before 
use in the ATP splitting experiment Noo 4, Table V by ion exchange 
chromatography on DEAE celluloses The DEAE cellulose was washed in 
acid and base as described by Peterson and Sober (235) and then equili-
brated in two to three volumes of one M acetic acid-triethylamirie pH 
5o0o After equilibration the r~sin was filtered.and washed two to 
three times with deionized water and finally suspended in waters The 
ATP-8-14c was then applied to a column 1o1 x 1 om2 and eluted with a 
linear gradient consisting of 100 ml each of Oo5 a.nd 1o0 M acetic acid-
triethylamine pH 5e0j respectivelyo This system quite easily separated 
ADP and AMP from ATPo The fractions containing ATP were then lypholyzed~ 
taken up in methanol a.n.d dried down five to six times in order to free 
the ATP of any remaining triethylamine .. The ATP-B-14c was then taken 
up in one ml of water and used in the ATP splitting experimento 
The enzymes used for identification of Na.MN were the following~ 
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potato acid phosphatase which was dissolved in a solution of five mg/ml 
in water and then assayed in the presence of Oe1 N acetate buffer pH 
408 for two hours, and phosphodiesterase type II from Crotalus adamanteus 
venom which was used at pH 7o5o Both enzymes were obtained from Sigma 
Chemical Coo 
Chemicals 
PRPP, AMP, ADP 7 and ATP were obtained from P-L Biochemical Inco 
Nicotinic acid-7=14c was obtained from Calbiochem Laboratories, and 
ATP=8-14c from Nuclear Chicago Corporationa GTP, UTP, CTP, ITPj and 
TTP were from Sigma Chemical Co. ADP-methylene-P was obtained from 
Miles Laboratories Inc~ DEAE cellulose and Dowex-1-chloride were 
purchased from Bio-Rad Laboratoriesy and Sephadex-G-100 from Pharmacia 
Fine Chemicals, Inco All other chemicals used were of reagent grade. 
CHAPTER III 
RESULTS 
Time Course of Reaction 
The stand.a.rd reaction mixture, as described in the experimental 
procedures section, was incubated with 0.01 ml of the enzyme, purified 
through the alumina Ct step, at 37° C, and the reaction stopped at dif-
ferent time intervals by heating for two to three minutes in a boiling 
water bath in order to determine the time course of the reaction. As 
shown in Figure 3, formation of NaMN appears to be linear with time 
until two and one-half hours, at which time the increase in-velocity 
approaches a plateau. Routine assays were eubsequently run for two 
hours. 
Effect of Protein Conoentr~tion on the Reaction 
The standard reaction mixture was incubated with various levels 
of enzyme purified through the alumina Or step, for two hours at 37° c. 
The reaction is l~near with protein concentration up to 15-20 p.g of 
protein per 0.15 ml total volume (Figure 4). Normal assays therefore 
contained enough enzyme to give 0.1 to 0.5 llflDOle Na.MN per hou~ de-
pending upon the preparation. 
pH Optimum 
The dialyzed calcium phosphate gel enzyme was used to determine 
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Figu.re 3 .. 
Time Course of Reaction 
Incubation mixtures containing a final concentration of nico-
tinic aoid-7-14c, 0.067 mM; PRPP, 1.33 mM; ATP, 0.667 mM; MgC12, 
3.,33 mM; phosphate ouffer, pH 7.5, 26.6 mM; and 0.25 units of 
enzyme in a final volume of 0.15 ml were allowed to react for the 
0 various time intervals indicated at 37 C and then assayed for 
the amount of Na:MN formed as described under experimental pro-
cedures. 
Figu.re 4. 
Velocity Versus Protein Concentration 
Incubation mixtures as described under Figure 3 were incubated 
for two hours at 37° C with various levels of enzyme purified 
through the alumina Cy stepo The incubations were then stopped 























the pH optimum. This was used since the alumina Ct enzyme was in 0.1 M 
phosphate buffer pH 7.5. This buffer .was too concentrated to allow a 
wide variable range of pH even when other buffers were present in four-
fold excess. The dialyzed enzyme was therefore incubated for two hours 
at 37° C in the normal way with the exception that the pH of the phos-
phate buffer was varied. As can be seen a fairly normal pH curve is 
obtained with an optimum at pH 7.5 (Figure 5). 
Determination of Niacin Ribonucleotidase Activity 
It has been mentioned previously that Nakamura~~. (210) re-
ported the conversion of NaMN pyrophosphorylase to niacin ribonucleo-
tidase in the absence of ATP. When NaMN-7~14c (eight mp.mole) was incu-
bated with the purified NaMN pyrophosphorylase in the presence of MgC12 
0 and phosphate buffer, pH 7.5 for two hours at 37 C, there was no ap-
parent conversion to nicotinic acid ribose-14c or nicotinic acid-14c 
(Table II). When the same compounds were incubated with the crude 
extract of acetone powder under similar conditions, there was con-
siderable ribonucleotidase activity present. Thus the protein respon-
sible for the conversion of niacin to NaMN appears to be separable from 
the protein which catalyzes the dephosphorylation of NaMN. Results 
reported here are in contrast with those reported by Nakamura~~· 
(210) and will be discussed in more detail later. 
Velocity Versus Nicotinic Acid Concentration 
Imsande and Handler (171) reported the stimulation of NaMN pyro-
phosphorylase activity by ATP. A study was made of this phenomenon and 
the results are shown in Figure 6. In this experiment, the purified 
Figure 5. 
Effect of pH on the Reaction 
Reaction mixtures as described under Figure 3, using phosphate 
buffers with different pH values, were incubated under standard 
conditions for two hours with.0.27 units of enzyme purified through 
the calcium phosphate gel step. The. amount of Na.MN produced was 
then determined as described under experimental procedures. 
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SEPARATION OF NaMN-PYROPHOSPHORYLASE AND -PHOSPHATIDASE 
NaMN Pyrophosphorylase (mµmole/hr) 
NaMN des-NAD+ Total Crude· 
Pur. 
Crude 19.0 63 82.0 
Purified 35.5 0 35.5 2.3 
NaMN Phosphatidase (mµmoles/hr) 
NA NAR Total Crude 
Pur. 
Crude 210.0 107 317.0 
Purified 2.2 0 2.2 143 
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enzyme was incubat.ed for two hours at 37° C with increasing concentra-
tions Of nicotinic aoid-14c both in the presence and absence Of 6.67 X 
10-4 M ATP. (The concentration of PRPP and Mg++ were as described 
under Figu.re 3.) As can be seen, at low concentrations of nicotinic 
acid, ATP shows a marked stimulatory effect, i.e., at 6.7 x 10-6 Ma 
five-fold stimulation occurs. However, at high concentrations of su.b-
strate, ATP apparently has no effect upon the initial velocity of the 
reaction. When a Lineweaver-Burk plot was made, it was founq that ATP 
lowers the apparent~ forniootinic acid from 2.1 x 10-5 M.to 2.5 x 
10-6 M. Thus ATP definitely appears to stimulate pyrophosphorylase 
activity at low concentrations of nicotinic acid. (See Figure 7.) 
In order to be sure tha..t there was no binding of ATP to the enzyme, 
the purified enzyme was further treated with charcoal (one mg/ml). 
After treatment, the enzyme was again incubated as before with in-
creasing concentrations of nicotinic acid-14c both plus and minus ATP. 
Table III shows essentially the eame resu.lts as described above. PRPP 
was essentially free of ATP and nicotinic acid-14c is routinely puri-
fied before use so that no ATP is present in this material. Therefore, 
unless the ATP is so tightly bound to the enzyme that treatment with 
charcoal cannot remove it, the reaction can proceed without ATP as 
long as the concentrations of the su.bstrates are high enough. 
Velocity Versu.s PRPP Concentration 
Since ATP stimulated pyrophosphorylase activity at low concentra-
tions .of nicotinic acid, it was of interest to investigate the effect 
of ATP at l.ow concentrations of PRPP. As shown in Figure 8, ATP, 6.67 
x 10-4 M, causes an even more striking stimulation under the·se conditions • 
. ' 
Figure 6. 
Velocity of Reaction Ver$Us Nicotinic Acid Concentration 
Standard reactio~ mixtures as described under Figure 3 with 
various levels of nicotinic acid-14c concentrations were incu-
bated with 0.27 units of enzyme for two hours at 37° C and then 
assayed for the amount of NaMN formed in the usual manner. 
o = + 6.67 x 10-4 M ATP; • = - ATP. 
Figure 7. 
Lineweaver-Burk Plot of Reaction Velocity Versus 
Nicotinic Acid Concentration 
-4 o = + 6.67 x 10 M ATP; • = - ATP. 
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TABLE III 
VEiLOCITY OF REACTION VERSUS NICOTlNIC ACID CONCENTRATION 
WITH CHARCOAL TREATED ENZYME 
Nicotinic Acid mpmole/hr of Na.MN Produced 














2Th1s figure unusually low and when repeated experiment, did not 
observe this low figure •. 
Figure 8. 
Velocity of Reaction Versus PBPP Concentrations 
S.tandard reaction mixtures as described under Figure 3 with 
various levels of PBPP concentrations were incubated with 0.26 
units. of enzyme for two hours at 37° C and then assayed for the 
a.mount of product formed in the usual manner. 
-4 o = + 6.67 x 10 M ATP; e. = - ATP. 
Figu.re 9. 
Lineweaver-!urk Plot of the Reaotion Velooity 
Versus P:RPP Concentration 
o = + 6.67 x 10-4 M ATP; • = - ATP. 
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At low concentrations of PRPP, ATP causes an eight to ten-fold increase 
in activity while at higher concentrations the stimulation is not as 
pronounced. The apparent K for PRPP is decreased from 5 x 10-4 Min 
m 
the absence of ATP to 4 x 10-5 Min the presence of ATP (Figure 9). 
In order to determine if PRPP may be an activater of the enzyme as 
well as a substrate, a Hill plot was made (Figure 10). However, the 
slope. did not indicate this, being very close to one both in the 
presence and absence of ATP. Therefore, PRPP apparently functions 
only as a substrat.e for the enzyme. 
Molecular Weight 
Due to the fact that ATP stimulates the reaction at low substrate 
concentration, a study to determine if ATP caused a change in the mo-
lecular weight of the enzyme was carrie~ out. A Sephadex G-100 column 
(1.7 x 100 cm2) was packed in 0.05 M phosphate buffer pH 7.5 containing 
0.1 M KCl. After the column had equilibrated for two or three days* 
the column was calibrated using bovine serum albumin, ovalbumin, and 
cytochrome c as standards. When the column was calibrated, 95 mg of 
the enzyme, purified past the calcium phosphate step, six mg cyto-
chrome c and two mg blue dextran were suspended in two ml of the phos-
phate buffer mentioned above and eluted. 
Three ml fractions were collected and every other tube was assayed 
for enzyme activity. Figure 11 shows a typical profile as the protein 
is eluted off of the column. It can be seen that enzyme activity was 
localized between fractions 34-48 with a peak at 41. When.the experi-
ment was repeated after the column had been equilibrated with 10-4 M 
ATP, it was found that the same elution pattern existed with enzyme 
Figure 10. 
Hill Plots of Na.MN Pyrophosphoryla.se Activity as a. 
.Function of PRPP Concentrations 
v = a.mount of Na.MN produced per ml enzyme solution per hour 
at 37° C under normal reaction conditions. PRPP concentration 

















































Elution of Na.MN Pyrophospho:rylase From 
a Sephadex 0-10.0 Column 
After reading the absorbancy at 260 and 412 mµ, 0.05 ml of 
eve:ry other fraction were incubated at the conditions under 
Figu.re 3 and assayed for the amount of product formed. -- = 
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activity coming off in the same fractions. Thus it was concluded that 
the enzyme does not dissociate in the absence of ATP. The concentra-
tion of the enzyme was one half or less than the concentration used in 
the standard assays thereby eliminating any dilution factor as the pre-
vention of dissociation. Figure 12 shows the calibration curve for the 
0-100 column and the molecular weight for Na.MN pyrophosphorylase which 
is approximately 77,000. 
The calcium phosphate step was used for the determination of the 
molecular weight because any purification beyond this step caused the 
enzyme to become extremely labile. 
Nucleotide Specificity 
Several different di- and trinucleotides were substituted for ATP 
to tes"I; their effect u~on the velocity of the reaction at low substrate 
concentration. As can be seen in Table IV, when the enzyme, purified 
through the alumina Cr step, was incubated with 6.67 x 10-6 M nicotinic 
acid and 13.3 x to-4 M PRPP, all.other conditions being standard, none 
of the nucleotides were as effective as ATP. The final concentration 
of all nucleotides was 6.7 x 10-4 M, Guanosine triphosphate (GTP) 
partially stimulated activity while on the other hand thymidine ~ri-. 
phosphate and possibly adenosine monophosphate caused a slight inhibi-
tion .. Adenyl diphosphate '4,r-meteylene) phosphate (ADP-meteylene-P) 
was also tested for stimulatory activity. As can be seen, instead of 
stimulation of activity, it appeared to inhibit the enzyme, Thus the 
enzyme seems to be fairly specific in its requirement of nucleotides 
for activation. 
Figure 12. 
Molecular Weight of Na.MN Pyrophosphorylase 
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NUCLEOTIDE SPECIFICITY FOR ACTIVATION OF NaMN 
PYROPHOSPHORYLASE ACTIVITY 
Nucleotiie 












Effect of Increasing Concentrations of ATP 
Na:MN pyrophosphorylase was incubated with nicotinic acid-14c 
(6.67 x 10-6 M), PRPP (13.3 x 10-4 M) and increasing concentrations of 
ATP (Figure 13). There appeared to be little or no stimulation of the 
enzyme at concentrations below 5 x 10-5 M ATP. Above this concentra-
tion an increase in initial velocity is seen with increasing concentra-
tions until a maximum is approached at 6.67 x 10-4 M. When a Lineweaver-
Burk plot was made, linearity could not be obtained as seen in Figure 
14A. At high concentrations, the reaction velocity is greater than 
that expected from extrapolation of data obtained at lower concentra-
tions. When the amount of Na:MN formed in the absence of ATP was sub-
tracted from the amount formed when ATP was present and a Lineweaver-
Burk plot of this data was made, a straight line could be observed. 
however (Figure 14B). The apparent Km obtained from this plot was 
2 x 10-3 M. This unusually high Km may be explained since the Vmax is 
automatically lowered upon subtraction of the constant amount of Na:MN 
produced in the absence of ATP, therefore increasing the Km. The sig-
nificance of this "Km" is presently not understood. The fact that a 
straight line relationship can be observed under the latter conditions 
indicates that a site on the enzyme is being saturated. Whether or not 
this site is independent of the sites responsible for binding PRPP and 
nicotinic acid is impossible to say from this experiment. Thus ATP 
does not behave as a normal substrate for this reaction and the kinetic 
behavior of this compound would indicate that it activates the pyro-
phosphorylase in some manner analogous to an allosteric modifier. 
Figure 13. 
Velocity of Reaction Versus ATP Concentration 
Incubation mixtures contained the standard reaction mixture 
·th th t· th t th t t· f · t· · ·d 14c wi e excep ion a e concen ra ion o nico inic aci -


















[ATP] x 10-4"M .. 
Figure 14. 
Lineweaver-Burk Plot of the Reaction Velocity 
Versus the ATP Concentration 
A. Before subtracting the amount of Nal\llN produced in the 
absence of ATP. 
· B. After subtracting the amount of NaIVIN produced in the 
absence of ATP. 
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Substrate Cooperation Effects 
When low levels of PRPP were used i.e., 6.7 x 10-5 M, in conjunc-
tion with varying the concentration of nicotinic acid-14c, it was found 
that in the absence of ATP, an effect known as substrate cooperation 
was observed (Figure 15)o Thus at low concentrations of PRPP, nico-
tinic acid activates the enzyme in the absence of ATP. At high levels 
of PRPP (13 x 10-4 M) this effect is lost. When ATP was present, this 
effect is also lost. When Hill plots of the data of Figure 6 were made 
for nicotinic acid it was found that a slope greater than one existed 
both in the presence and absence of ATP (Figure 16). This indicates 
that nicotinic acid is involved both as a substrate and an activator 
in contrast to PRPP which functions only as a substrate for the reaction 
(Figure 10). 
Conversion of ATP to ADP During the Reaction 
The kinetics of the reaction catalyzed by Na:MN pyrophosphorylase 
in the presence and absence of ATP seemed to indicate that ATP acts as 
an allosterio modifier. Although no change in molecular weight could 
be observed, it seemed possible that ATP may change the conformational 
structure of the enzyme without affecting the molecular weight. 
Experiments using nicotinic acid-7-14c and ATP-8-14c were per-
formed to determine whether or not ATP actually took part in the reac-
tion when it was present. To do this, 2.5 units of enzyme purified 
through the alumina~ step were incubated with 6.67 x 10-4 M nicotinic 
acid-7-14c, 2o4 x 10-4 M ATP-8-14c, and 2.67 x 10-4 M PRPP as described 
under experimental procedures. After two hours incubation time, assays 
for the amount of Na:MN-14c and A:OP-14c formed were made by eluting the 
Figure 15. 
Substrate Cooperative Effect With Nicotinic Acid 
Standard reaction conditions were used with 6.67 x 1~5 M 
PRPP and various levels of nicotinic acid~14c in the absence 
of ATPo The incubation mixtures were then assayed for the 
amount of NaMN-14c formed in the usual manner. 
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[Nicotinio Acid] x 10-6 M 
Figure 16. 
Hill Plots of Na.MN Pyrophosphorylase Activity as 
a Function of Nicotinic Acid Concentrations 
v = amount of Nall[N' produced per ml of enzyme solution per 
hour at 37° C under standard reaction conditions. Nicotinio 
acid concentration is expressed as moles/liter. (A)+ A'l'P, 
(B) - A'l'P. 
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reaction mixture from a Dowex-1-formate column. As ca.n be seen in 
Table v, there appeared to be some ATP converted to ADP. Much difficulty 
was encountered with this experiment since the ATP-14c obtained from 
Nuclear Chicago Corporation contained about five percent contaminating 
ADP-14c or some substance that co-chromatographed with ~his compound. 
All efforts to purify the ATP (including paper chromatography, column 
chromatography over Dowex-1-formate, and high voltage electrophoresis) 
were in vain (with the exception of purification over DEAE cellulose-
a.ceta.te). Either such efforts failed to purify the ATP to any signifi-
cant extent or else the recovery was so low as to make the. method im-
practical. Although ATP could be purified with the use of DEAE oellu-
lose-acetate as described under experimental procedures a.nd as used in 
experiment 4 of Table V, the triethylamine salt of the ATP obtained in 
this manner inhibited the enzyme 30 to 50 percent. Efforts to convert 
this to the sodium salt resulted in such low recovery as to a.gain make 
the method impractical. When the concentration of nicotinic acid was 
increased ten fold there followed an increase in the amount of Na.MN 
formed, experiment 3, Table V, but no increase in the amount of ATP 
converted to ADP was observed. Thus at the present time it is impos-
sible to say if there is a stoichiometric relationship between the 
amount of Na.MN produced and the amount of ATP converted to ADP, but it 
is evident that some ADP is formed during the reaction when ATP is 
present. Therefore, ATP takes part in the reaction when it is present; 
however, as shown earlier, it appears not to be an absolute requirement 
for the reaction when nicotinic acid and PRPP are present in high enough 
co;ncentrations. 
TABLE V 












None; NA~ 6.7 x 10 SM 
















































1Background for Na.MN and ADP inherent in experiment since 
detected products by isotopic technique and thus observed some back-
ground in system. . . 
2Numbers in parentheses refer to amount of Na.MN and A.DP formed 
when nicotinic acid concentration increased to 6.7 x 10-5 M. 
3unusually high blank not usually observed. 
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~eriment 4 performed after purification of ATP over DEAE cellu-
lose as described in methods and procedures. 
CHAPTER IV' 
DISCUSSION 
It has been observed previously in this dissertation that the 
pathways and control of NAD+ biosynthesis are varied and complex. This 
seems to be true especially in the case of mammalian systems., In this 
system 1 both tryptophan and nicotinic acid. may serve as starting ma-
terials for N.A:Il biosynthesisg thus it must be very important for the 
cell to have a means of control whereby it can regulate one or both of 
these pathwayso 
NaMN pyrophosphorylase appears to be one of the control points of 
this biosynthesis when :rd.coti:nic acid is used as the sta:rting materiaL 
As mentioned a·bove 9 this enzyme is rate controlling in many organisms 
including £1. £ill (205) i other related coliforms (206)? ],o _§!UJ?_tilis 
(207,-209), and last but rwt least with ma.1llll'!alian systems (1"/0 9 2-W)o 
Imsa.nde (208) mentioned that ATP stimulated the activity of' NaJl!JrJ pyro-
phosphorylase of beef li.re:ro Curiously enough~ this and the e:rythro= 
cyte system appear to be the only two systems which do not show a:n ab--
solute requirement for ATP (208)0 
When it was reported that NaMN pyrophosphorylase could be dis-
sociated in the absence of ATP to form Na.MN ribonucleotid.ase (210L it 
-became of interest to us to study this systemo However~ when we tried 
to separate these two activities it was obvious that they were quite 
easily separable and apparently have no direct reiationship to one 
80 
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anothero This has been confirmed with the yeast enzyme where Ogasawara 
and Gholson (236) found that the two enzyme activities were again quite 
easy to separateo Since this time 1 Honjo .tl .§!do (2.37) have retracted. 
their previous statement concerning this point and thus it appears to 
be well established tha·t the tw"J enzymes are non-:relatedo 
When a study was made i;o dete::rmi.n.e the effect of ATP on the i.ni tial 
veloc::i ty J.:t was fciu:t1d that a,i3 had been. prev'iou.sly :reported ( '170) ATP 
stimulated the actiYity five to ten :fold at low nicoti:nic acid conoen-
tra't:ions. On the o·ther hand~ it had not been reported that the reaction 
velocity was inrlependent of ATP at higher concent:rations of nicotinic 
acid (F'igu.re 6) o Therefore the ATP in some mi.known manner changes either 
the reaction mechanism or the conformation of the enzyme causing a pro-· 
rwunced change o:f the K for both the nicotinic acid and the PRPPo Since m 
the max.:imurn yeloci ty is the same whether in the prese:rwe o:r absence of 
NrP it is i~easoned that without ATP the enzyme requires more substrate 
in order to ·be satnrated. Thu.s at higher con0ent:rations ~)f nic()tinic 
ac:id and PHPP maximu.m velocity is attained in the absence of ATPo 
1rhe substrate cooperative effect of nicotini;;} acid may a1so be o:f 
some significance in the reg1.11a tion o:f the enzyme acti vj_ ty (Figure ·15). 
The B.511 p.lots (:F'igu.re i6) also :show that n:ic.otinic acid is itnrolved 
with activation of the enzyme., This effect is not urwommo:n wi.th 
systems :requiring two or more sul)strateso Sanwal ~ a;l.~ (238) report<:"!d 
that isocitrate has an activating effect on isooitrate d.ehydrogenase of 
~wros~.. Another e.xa.mpl.e of this is the activation of deo.x:yth,_ymi-
dine kinase by ATP (239)0 Probably the mod famous system of this type 
is the mxbstrate cooperative ef:feut of hemaglobin with oxygen uptake 
(230). Therefore nicotin.ic acid serves two functions with this enzyme: 
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that of a substrate and as an activator. 
ATP also stimulates the velocity of NaMN pyrophosphorylase at low 
concentrations of PRPP (Figure 8). This effect is again striking in 
that an eight to ten fold stimulation in velocity is observed at low 
concentrations of PRPP and the Km is decreased about ten fold (Figure 
9)o It is also interesting to note that PBPP is apparently not an 
activator of the enzyme as is nicotinic acid as noted by the Hill plots 
made for th:i.s substrate in the presence and absence of ATP (Figu.re 10). 
Therefore the two subst:r•ates are not equivalent in their functions. 
These effects may play a si.g.ni.ficant role in ;the control of NaMN 
pyrophosphorylase. In the absence of ATP, the enzyme activity may be 
controlled to some extent by the concentration of nicotinic acid and 
PRPPo Since the Ks of these substrates are much higher in the absence m 
of ATP, the physiological concentrations of substrates may not be suf-
ficient to saturate the enzyme and the rate of reaction would ·be pro-
portional to substrate concentrationo The effect of ATP stimulation 
is another means of controlling NaMN pyrophosphorylase activity at low 
concentrations of substrate. In all probability, this is the more sig-
nificant of the two methods of regulating this activity. By some means 
yet unknown, A'rP appears to act by drastically lowering the K for both 
m 
substrates suggesting that ATP is acting as an allosteric modifier. 
However, this hypothesis does not explain the observed cleavage of ATP 
to ADP which may or may not be stoichiometric with NalV!N formation. The 
fact that ADP-methylene-P inhibits the enzyme activity may also suggest 
that ATP is split when present. Thus when an analog such as this one 
is present, the reaction is inhibited because the analog cannot be 
cleavedo Although GTP can substitute for ATP to some degree it is not 
as efficient as ATPo In this respect? the enzyme of ].o subtilis (207, 
208) is similar to 'the beef live:r systemo Although ATP is an absolute 
requirement in ].o ~ for Na.MN formation, it apparently acts as a 
regulating mechanism as evidenced by the fact that ATP is the rate 
limiting substrate for the reaction (207)0 Fu.rthermore 1 ATP appears to 
have a binding site distinct from that of the other two substrates 
(208). This could also be speculated of the beef liver enzyme since 
the reaction can certainly proceed in the absence of ATP. 
It has been suggested that ATP may in some manner activate the 
pyridine ring (208) 6 This is reasoned sin.ce the free energy of hydroly-
sis of the ribosyl-niootinamide bond of NAD+, whioh is formed in the 
presence of NaJm pyrophosphoryl1:u.1e, has been estimat(..;d ·to be approxi-
mately 9000 calo:riel!!/mole (240). O:n th~ other hand, the free energsr 
of hydrolysis of the ribosyl-pyrophosphate bond of PRPP should not be 
too different from tha.t of rfbcH:le-1-phosphate; which is approximately 
4800 oalories/moleo Thus it a.ppea,rs that a bond is broken releasing 
4800 calories/mole whi.ch drives the formation of another bond requiring 
9000 calories/moleo This cannot be explained in terms of the established 
law of thermodynamics and it may be that ATP activates the pyridine ring 
perhaps in a concerted reaction which resu.l ts in the formation of ADP 
and Pio On the other hand this could not explain why the reaction can 
proceed in the absence of ATPQ 
The possibility also exists that ATP may change the conformational 
structure of the enzyme and in so doing require the conversion of ATP 
to AI>Po This may alter the conformational structure such that as the 
enzyme catalyzes the reaction enough energy is released from the enzyme 
to enhance the formation of the pyridine-ribose bondo Again this does 
not explain the large quantity of ATP converted to ADP since the amount 
of enzyme present compared to the substrate should be quite small. Thus 
neither of these hypotheses can completely explain all of the datao 
In summary, NaMN pyrophosphorylase appears to be regulated by two 
mechanisms. The first and least significant is that of activation by 
nicotinic acid. The second, and most pronounced is by ATP, where it 
causes a marked stimulation of activity at low substrate concentrations, 
but is not essential for activity at high substrate concentrations. 
ATP may not be an allosteric modifier as described by Monod~ ~. (241) 
because it is cleaved to ADP. Therefore this 1 enzyme appears to be very 
unique in its mechanism of action. It i.s regulated in some manner by 
ATP but this mechanism is as yet not understood. Further investigation 
will be necessary in order to elucidate the details of this mechanism. 
SUMMARY 
Nicotinic acid mononucleotide pyrophosphorylase was partially 
purified from beef liver acetone powder., NaMN pyrophosphorylase was 
shown to be distinct from NaMN phosphatidase. When the enzyme was 
incubated with high levels o:f PRPP and various levels of nicotinic 
acid, both in the presence and absence of ATP, it was found that ATP 
stinmlated the activity of the enzyme five to ten fold and decreased 
the Km approximately ten fold. Conversely, when the concentration of 
niootinic acid was kept constant and the concentration of PRPP was 
varied 7 again an eight to ten fold stimulation by ATP was observed at 
low concentrations of PRPP and the K111 was lowered a·bout ten fold. The 
molecular weight of the enzyme did not appear to change in the presence 
and absence of ATP being approximately 77,000 in both cases. The 
enzyme is rather specific for Nl1P with GTP replacing ATP to a slight 
degree and other nucleotides tested showing no effect" Nico-tinic acid 
also appeared to have a slight stimulatory effect as shown by substrate 
cooperation in addition to serving as a substrate while PRPP appears to 
only serve as a subst:rate for this enzyme. When ATP-14c and ni.cotinic 
acid-14c were incubated simultaneously and assayed for the amount of 
NaMN-14c and ADP-14c formed, it was found that ATP was converted to 
ADPo The data obtained were not sufficiently precise to determine 
whether ADP formation is stoichiometric with NaMN formationQ The kinet-
ics of the reaction indicate that NaMN pyrophosphorylase is an allo-
steric protein with ATP serving as the allosteric modifier. However, 
the fact that ATP is converted to ADP during the reaction appears to 
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